These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 23434327

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
    Guzelmeric K, Alkan N, Pirimoglu M, Unal O, Turan C.
    Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of metformin compared with hypocaloric diet on serum C-reactive protein level and insulin resistance in obese and overweight women with polycystic ovary syndrome.
    Esfahanian F, Zamani MM, Heshmat R, Moini nia F.
    J Obstet Gynaecol Res; 2013 Apr; 39(4):806-13. PubMed ID: 23279603
    [Abstract] [Full Text] [Related]

  • 7. Polycystic ovary syndrome is associated with elevated plasma soluble CD40 ligand, a marker of coronary artery disease.
    Oktem M, Ozcimen EE, Uckuyu A, Esinler I, Pamuk B, Bayraktar N, Kulaksizoglu S, Zeyneloglu HB.
    Fertil Steril; 2009 Jun; 91(6):2545-50. PubMed ID: 18554599
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Serum resistin and adiponectin levels in young non-obese women with polycystic ovary syndrome.
    Arikan S, Bahceci M, Tuzcu A, Kale E, Gökalp D.
    Gynecol Endocrinol; 2010 Mar; 26(3):161-6. PubMed ID: 20148738
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Is the polycystic ovary syndrome the causative of the increase in inflammatory markers and metabolic risk?
    Rey-Roldan E, Perez Lana MB, Galluzzo L, Blanco G, Onetto C, Straminsky V, Nolting MP.
    Gynecol Endocrinol; 2013 Feb; 29(2):141-4. PubMed ID: 23116196
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Women with polycystic ovary syndrome have increased plasma chitotriosidase activity: a pathophysiological link between inflammation and impaired insulin sensitivity?
    Aydogdu A, Tasci I, Tapan S, Sonmez A, Aydogan U, Akbulut H, Uckaya G, Aydogdu S, Basaran Y, Meric C, Taslipinar A, Kurt I, Azal O.
    Exp Clin Endocrinol Diabetes; 2012 May; 120(5):261-5. PubMed ID: 22549343
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Leucocytosis in women with polycystic ovary syndrome (PCOS) is incompletely explained by obesity and insulin resistance.
    Phelan N, O'Connor A, Kyaw Tun T, Correia N, Boran G, Roche HM, Gibney J.
    Clin Endocrinol (Oxf); 2013 Jan; 78(1):107-13. PubMed ID: 22712547
    [Abstract] [Full Text] [Related]

  • 20. Postprandial response of ghrelin and PYY and indices of low-grade chronic inflammation in lean young women with polycystic ovary syndrome.
    Zwirska-Korczala K, Sodowski K, Konturek SJ, Kuka D, Kukla M, Brzozowski T, Cnota W, Woźniak-Grygiel E, Jaworek J, Bułdak R, Rybus-Kalinowska B, Fryczowski M.
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():161-78. PubMed ID: 18812636
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.